JP2006528206A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006528206A5 JP2006528206A5 JP2006529424A JP2006529424A JP2006528206A5 JP 2006528206 A5 JP2006528206 A5 JP 2006528206A5 JP 2006529424 A JP2006529424 A JP 2006529424A JP 2006529424 A JP2006529424 A JP 2006529424A JP 2006528206 A5 JP2006528206 A5 JP 2006528206A5
- Authority
- JP
- Japan
- Prior art keywords
- less
- lornoxicam
- thiazine
- thieno
- cox
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OXROWJKCGCOJDO-JLHYYAGUSA-N Lornoxicam Chemical compound O=C1C=2SC(Cl)=CC=2S(=O)(=O)N(C)\C1=C(\O)NC1=CC=CC=N1 OXROWJKCGCOJDO-JLHYYAGUSA-N 0.000 claims 3
- 102100017796 APP Human genes 0.000 claims 2
- 108060000460 APP Proteins 0.000 claims 2
- 206010001897 Alzheimer's disease Diseases 0.000 claims 2
- 102100006335 PTGS1 Human genes 0.000 claims 2
- 102100015381 PTGS2 Human genes 0.000 claims 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 claims 1
- LFDVVRCMBXCTRV-UHFFFAOYSA-N 1-[6-chloro-2-methyl-1,1-dioxo-3-(pyridin-2-ylcarbamoyl)thieno[2,3-e]thiazin-4-yl]oxyethyl N-ethoxycarbamate Chemical compound CN1S(=O)(=O)C=2C=C(Cl)SC=2C(OC(C)OC(=O)NOCC)=C1C(=O)NC1=CC=CC=N1 LFDVVRCMBXCTRV-UHFFFAOYSA-N 0.000 claims 1
- GXBZUQWRRATBGE-UHFFFAOYSA-N 6-chloro-4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[3,2-e]thiazine-3-carboxamide Chemical compound OC=1C=2C=C(Cl)SC=2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 GXBZUQWRRATBGE-UHFFFAOYSA-N 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 210000001218 Blood-Brain Barrier Anatomy 0.000 claims 1
- 101700050822 CKX1 Proteins 0.000 claims 1
- 108010037464 Cyclooxygenase 1 Proteins 0.000 claims 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 claims 1
- 101710040931 PTGS1 Proteins 0.000 claims 1
- 101710040930 PTGS2 Proteins 0.000 claims 1
- 201000001320 atherosclerosis Diseases 0.000 claims 1
- 229960002986 dinoprostone Drugs 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 229960002202 lornoxicam Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000004962 physiological condition Effects 0.000 claims 1
- 231100000486 side effect Toxicity 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Claims (3)
- アルツハイマー病(AD)またはアテローム性動脈硬化症の治療または予防用医薬組成物を製造するための、
シクロオキシゲナーゼ−１およびシクロオキシゲナーゼ−２(COX-1およびCOX-2)を阻害し；
生理的条件下で血液脳関門を通過できず；および
アミロイド先駆体タンパク質(APP)のプロスタグランジンE2誘発性誘発を減少させる；ロルノキシカムおよびロルノキシカム類縁体の使用。 - 物質の投与が重篤な望ましくない副作用を引き起こす割合が、１％以下、好ましくは0.5％以下、より好ましくは0.1％以下、特に好ましくは0.05％以下であることを特徴とする請求項１に記載の使用。
- ロルノキシカム類縁体が、以下のグループから選ばれることを特徴とする請求項１または２に記載の使用：
6-クロロ-4-(1-(エトキシカルバモイルオキシ)-エトキシ)-2-メチル-N-(2-ピリジル)-2H-チエノ-(2,3-e)-1,2-チアジン-3-カルボン酸アミド-1,1-ジオキシド；
6-クロロ-4-ヒドロキシ-2-メチル-3-(2-ピリジル-カルバモイル)-2H-チエノ[3,2-e]1,2-チアジン-1,1-ジオキシド。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0081903A AT413944B (de) | 2003-05-27 | 2003-05-27 | Verwendung von oxicam-verbindungen |
| ATA819/2003 | 2003-05-27 | ||
| PCT/AT2004/000185 WO2004105766A2 (de) | 2003-05-27 | 2004-05-27 | Verwendung von lornoxicam oder lornoxicam-analoga verbindungen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006528206A JP2006528206A (ja) | 2006-12-14 |
| JP2006528206A5 true JP2006528206A5 (ja) | 2007-07-05 |
| JP5597339B2 JP5597339B2 (ja) | 2014-10-01 |
Family
ID=33479909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006529424A Expired - Fee Related JP5597339B2 (ja) | 2003-05-27 | 2004-05-27 | オキシカム化合物の使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8129370B2 (ja) |
| EP (1) | EP1626726B1 (ja) |
| JP (1) | JP5597339B2 (ja) |
| KR (1) | KR101134244B1 (ja) |
| CN (3) | CN102218067A (ja) |
| AT (2) | AT413944B (ja) |
| CA (1) | CA2526816C (ja) |
| DE (1) | DE502004001499D1 (ja) |
| DK (1) | DK1626726T3 (ja) |
| ES (1) | ES2271893T3 (ja) |
| PL (1) | PL1626726T3 (ja) |
| RU (1) | RU2366425C2 (ja) |
| WO (1) | WO2004105766A2 (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005238220A1 (en) * | 2004-04-29 | 2005-11-10 | Binder, Eva | Enantiomer-pure hexahydro- pyrrolocyclopenta- pyridine derivatives |
| EP2365804B1 (en) * | 2008-11-13 | 2015-05-06 | Modgene, Llc | Reduction of amyloid-beta load in non-brain tissue |
| AU2012332416B2 (en) | 2011-11-01 | 2017-06-15 | Modgene, Llc | Compositions and methods for reduction of amyloid-beta load |
| CN115227655A (zh) * | 2022-08-17 | 2022-10-25 | 海南锦瑞制药有限公司 | 注射用氯诺昔康的制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU518216B2 (en) * | 1977-09-06 | 1981-09-17 | Hafslund Nycomed Pharma Aktiengesellschaft | Thienothiazine derivatives |
| JPS58146040A (ja) * | 1982-02-24 | 1983-08-31 | Pioneer Video Kk | 光学式情報記録原盤 |
| DE3371082D1 (de) | 1982-09-09 | 1987-05-27 | Hoffmann La Roche | Thieno(2,3-e)-1,2-thiazine derivatives |
| NZ226477A (en) | 1987-10-29 | 1990-07-26 | Cl Pharma | Substituted thieno (2,3-e)-1,2 thiazine derivatives and pharmaceutical compositions |
| US5192753A (en) * | 1991-04-23 | 1993-03-09 | Mcgeer Patrick L | Anti-rheumatoid arthritic drugs in the treatment of dementia |
| AT400437B (de) * | 1993-12-14 | 1995-12-27 | Chem Pharm Forsch Gmbh | Neue n-heterocyclische thienothiazincarboxamide, verfahren zu ihrer herstellung und ihre verwendung |
| US5643960A (en) * | 1994-04-15 | 1997-07-01 | Duke University | Method of delaying onset of alzheimer's disease symptoms |
| US6184248B1 (en) * | 1996-09-05 | 2001-02-06 | Robert K. K. Lee | Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| CA2279651A1 (en) * | 1996-09-05 | 1998-03-12 | Massachusetts Institute Of Technology | Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| EP1216037A2 (en) * | 1999-09-21 | 2002-06-26 | Emory University | Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| AU5702201A (en) * | 2000-04-13 | 2001-10-30 | Mayo Foundation | Abeta<sub>42</sub> lowering agents |
| US6429223B1 (en) * | 2000-06-23 | 2002-08-06 | Medinox, Inc. | Modified forms of pharmacologically active agents and uses therefor |
| TWI256305B (en) * | 2000-08-18 | 2006-06-11 | Pharmacia Corp | Oral fast-melt pharmaceutical composition of a cyclooxygenase-2 inhibitor and process for preparing the same |
| JP2002363104A (ja) | 2001-04-04 | 2002-12-18 | Sankyo Co Ltd | 炎症性サイトカイン産生抑制剤の新規医薬用途 |
| EP1287833B1 (en) * | 2001-08-20 | 2007-10-10 | FUJIFILM Corporation | Liposome containing hydrophobic iodine compound and X-ray contrast medium comprising said liposome |
| US20030225054A1 (en) * | 2002-06-03 | 2003-12-04 | Jingwu Duan | Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents |
-
2003
- 2003-05-27 AT AT0081903A patent/AT413944B/de not_active IP Right Cessation
-
2004
- 2004-05-27 CN CN2011100997401A patent/CN102218067A/zh active Pending
- 2004-05-27 JP JP2006529424A patent/JP5597339B2/ja not_active Expired - Fee Related
- 2004-05-27 PL PL04734972T patent/PL1626726T3/pl unknown
- 2004-05-27 RU RU2005136864/15A patent/RU2366425C2/ru not_active IP Right Cessation
- 2004-05-27 AT AT04734972T patent/ATE339206T1/de active
- 2004-05-27 US US10/558,117 patent/US8129370B2/en not_active Expired - Fee Related
- 2004-05-27 CN CNA2004800143442A patent/CN1842338A/zh active Pending
- 2004-05-27 DE DE502004001499T patent/DE502004001499D1/de not_active Expired - Lifetime
- 2004-05-27 KR KR1020057022636A patent/KR101134244B1/ko active IP Right Grant
- 2004-05-27 CN CNA2008101754015A patent/CN101450057A/zh active Pending
- 2004-05-27 DK DK04734972T patent/DK1626726T3/da active
- 2004-05-27 ES ES04734972T patent/ES2271893T3/es not_active Expired - Lifetime
- 2004-05-27 WO PCT/AT2004/000185 patent/WO2004105766A2/de active Application Filing
- 2004-05-27 EP EP04734972A patent/EP1626726B1/de not_active Expired - Lifetime
- 2004-05-27 CA CA2526816A patent/CA2526816C/en not_active Expired - Fee Related
-
2009
- 2009-04-03 US US12/418,339 patent/US20090239852A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108883108B (zh) | 马赛替尼用于治疗肌萎缩侧索硬化症患者亚群的用途 | |
| US20030220374A1 (en) | Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors | |
| JP2010529118A5 (ja) | ||
| JP2007526328A (ja) | 単独および抗うつ薬と組み合わせた形のＣｏｘ−２阻害剤によって精神障害を治療または予防するための方法および組成物 | |
| JP2008533142A (ja) | α７ニューロンニコチン性受容体リガンドおよび抗精神病薬組成物 | |
| JP2015524444A5 (ja) | ||
| DE102005020882A1 (de) | Verwendung von Gaboxadol und Derivaten zur Behandlung von Kinase-induzierten Krankheiten | |
| JP2005525313A (ja) | ペルオキシソーム増殖剤応答性受容体−αアゴニストおよびシクロオキシゲナーゼ−２選択的阻害薬の組み合わせ並びにその治療的使用 | |
| NO20074407L (no) | Oral doseringsform omfattende rosiglitazon | |
| JP2005505539A (ja) | パーキンソン病の治療のためのｃｂ１受容体アンタゴニストと、脳のドーパミン作用性神経伝達を活性化する製品を含む組成物 | |
| BR112019025636A2 (pt) | método para tratar bexiga hiperativa, método para aumentar relaxamento de músculo liso da bexiga, e composição de dosagem unitária farmacêutica | |
| MA46268A (fr) | Dérivés de 5-[2-(pyridin-2-ylamino)-1,3-thiazol-5-yl]-2,3-dihydro-1h-isoindol-1-one et leur utilisation en tant qu'inhibiteurs doubles de phosphatidylinositol 3-kinase delta & gamma | |
| JP2009502937A5 (ja) | ||
| WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
| JP2006528206A5 (ja) | ||
| CN1291891A (zh) | 治疗肺慢性阻塞性疾病的方法 | |
| ES2271893T3 (es) | Utilizacion de compuestos de lornoxicam o analogos de lornoxicam. | |
| JP5263548B2 (ja) | イブジラストを有効成分とする脳動脈瘤の予防、形成抑制又は治療剤 | |
| RU2019113752A (ru) | Композиции апилимода и способы их применения при лечении болезни альцгеймера | |
| Mucke | Drug Repurposing Patent Applications October: December 2021 | |
| Skeith | Diltiazem/furosemide/sildenafil interaction | |
| TH128613B (th) | สารองค์ประกอบยาเม็ดแตกตัวในปากของลาโมไทรจีน | |
| Roche et al. | Aripiprazole ingestion in two pediatric patients | |
| WO2006137839A3 (en) | Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events | |
| Ng | Interstitial nephritis associated with omeprazole |